All Industries

Top Oncology Companies

290 Oncology companies, sorted by total funding raised.

Faeth Therapeutics

Data-driven company with deep understanding of how nutrients influence tumor growth

United StatesBiotech, Oncology
Series BTotal funding$92.0MOct 2025
Regor

Regor Therapeutics Group is a clinical-stage biotechnology company that discovers and optimizes p...

Cambridge, United StatesBiotech, Drug Discovery
Series BTotal funding$90.0MFeb 2021
Cleave Biosciences

Discovering and developing novel small molecule therapies for difficult-to-treat cancers

Burlingame, United States11–50Biotech, Oncology
Series BTotal funding$89.0MAug 2016
Auron Therapeutics

Auron Therapeutics is a clinical-stage biotechnology company targeting cell-state plasticity to i...

Newton, United States11–50Biotech, Healthcare
Series BTotal funding$87.8MFeb 2025
ApreaIPO

Develops small molecule therapeutics for cancer by reactivating mutant p53

DOYLESTOWN, United States11–50Biotech, Oncology
Venture RoundTotal funding$87.0MApr 2026
Cyllene Therapeutics

Cancer immunotherapy platform (formerly EG 427)

Paris, France11–50Biotech, Oncology
Series CTotal funding$86.0MJul 2026
Tentarix Biotherapeutics

Creates innovative protein therapeutics leveraging synthetic biology

San Diego, United States11–50Biotech, Oncology
Series BTotal funding$85.0MSep 2023
Alpheus Medical

Biotechnology company developing investigational drug-ultrasound combination therapy for brain ca...

Chanhassen, United States11–50Biotech, Healthcare
Series BTotal funding$84.0MMay 2025
Recludix Pharma

Recludix is a leader in developing platform approaches to discover potent and selective inhibitor...

San Diego, United States11–50Biotech, Oncology
Series BTotal funding$81.5MJan 2026
Mitra Biotech

Mitra Biotech is a global leader in personalized cancer treatment, using phenotypic platforms to ...

Woburn, United States11–50Biotech, Healthcare
Series CTotal funding$79.2MJul 2018
Notable LabsIPO

Personalized drug discovery for blood cancer.

Foster City, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$77.4MFeb 2023
Ensem Therapeutics

Pioneer in drug discovery leveraging Kinetic Ensemble platform for oncology precision medicines

Waltham, United States11–50Biotech, Drug Discovery
Extension RoundTotal funding$77.0MOct 2023
AnHeart TherapeuticsAcquired

Clinical-stage biopharmaceutical company developing precision oncology therapeutics, including ta...

New York, China51–200Biotech, Oncology
Series BTotal funding$75.6MDec 2021
TP
TetraLogic PharmaceuticalsIPO

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused o...

United States11–50Biotech, Oncology
Extension RoundTotal funding$75.3MSep 2010
Alpha Biopharma

专注于创新药物从临床研发到商业化运作成功;致力于开发临床急需的创新治疗药物

Shanghai, China11–50Biotech, Oncology
Series BTotal funding$73.0MApr 2022
Link Cell Therapies

Developing logic-gate CAR T cell therapies for solid tumors, founded by Stanford researchers in p...

Stanford, United States1–10Biotech, Oncology
Series ATotal funding$72.0MDec 2025
Anji Pharma (安济药业)Closed

Biotech focused on metabolic and oncology drug R&D

Shanghai, ChinaBiotech, Oncology
Series BTotal funding$70.0MSep 2021
PaigeAcquired

AI-powered computational pathology platform for cancer diagnosis and treatment, spun out of Memor...

New York, United States51–200Artificial Intelligence, Digital Health
Series BTotal funding$70.0MDec 2019
Chordia TherapeuticsIPO

IPO exit from SMBC Venture Capital portfolio

Fujisawa, JapanOncology
Series CTotal funding$69.0MMay 2022
HiberCell

Clinical-stage pharmaceutical company developing novel therapeutics that address the relapse and ...

New York, United States51–200Biotech, Oncology
Series BTotal funding$67.4MMay 2021
Rondo Therapeutics

Clinical-stage biotechnology company developing immune-engaging antibody therapeutics for cancer ...

United States11–50Biotech, Healthcare
Series ATotal funding$67.0MMar 2022
Loxo OncologyAcquired

Biopharma company developing targeted cancer therapies for genetically-defined patient populations

United States51–200Biotech, Oncology
Series BTotal funding$57.0MMay 2014
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series CTotal funding$56.3MJun 2013
Hope Medicine

Hope Medicine (HopeMed) is a clinical-stage biopharmaceutical company focused on researching, dev...

Shanghai, ChinaBiotech, Oncology
Venture RoundTotal funding$56.0MFeb 2024
Crown Bioscience

Biotech / Health

Santa Clara, United States501–1000Biotech, Healthcare
Series DTotal funding$55.4MMay 2014